Related Experiment Video
Updated: Feb 11, 2026

High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease
L M Bekris1, M Khrestian1, E Dyne2
1Cleveland Clinic, Genomic Medicine Institute, Cleveland, OH, United States.
Abstract:
Alzheimer's disease (AD) has been genetically and pathologically associated with neuroinflammation. Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial receptor involved in innate immunity. TREM2 rare protein coding genetic variants have been linked to AD. A soluble TREM2 (sTREM2) cleavage product is elevated in AD. It is unclear whether there is a relationship between elevated sTREM2 and markers of inflammation. The hypothesis of this investigation was that central and peripheral inflammation play a role in sTREM2 levels in AD. A consistent association of peripheral or central markers of inflammation and CSF sTREM2 levels was not found, suggesting a limited impact of general inflammation on sTREM2 levels. An association between peripheral sTREM2 levels and CSF sTREM2, as well as an association between CSF sTREM2 and a marker of blood brain barrier integrity, was observed in AD, suggesting a potential role of peripheral TREM2 in central TREM2 biology.
Insights
This study investigated the link between inflammation and soluble TREM2 (sTREM2) in Alzheimer's disease (AD). General inflammation did not significantly impact cerebrospinal fluid sTREM2 levels, but peripheral sTREM2 may influence central sTREM2 in AD patients.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Alzheimer's disease (AD) is linked to neuroinflammation.
- Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial receptor involved in innate immunity.
- Rare TREM2 genetic variants and elevated soluble TREM2 (sTREM2) are associated with AD.
Purpose of the Study:
- To investigate the relationship between central and peripheral inflammation and sTREM2 levels in Alzheimer's disease.
- To determine if general inflammation impacts cerebrospinal fluid (CSF) sTREM2 levels.
- To explore the potential role of peripheral TREM2 in central TREM2 biology.
Main Methods:
- Analysis of CSF and peripheral sTREM2 levels.
- Assessment of central and peripheral inflammation markers.
- Evaluation of blood-brain barrier integrity markers.
Main Results:
- No consistent association was found between peripheral or central inflammation markers and CSF sTREM2 levels in AD.
- Peripheral sTREM2 levels were associated with CSF sTREM2 levels in AD.
- CSF sTREM2 levels were associated with a marker of blood-brain barrier integrity in AD.
Conclusions:
- General inflammation appears to have a limited impact on CSF sTREM2 levels in Alzheimer's disease.
- Peripheral TREM2 may play a role in central TREM2 biology within the context of AD.
- Further research is warranted to elucidate the complex interplay between TREM2, inflammation, and AD pathogenesis.
Related Concept Videos
Factors Affecting Solubility
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Peripheral Artery Disease I: Introduction
Solubility Equilibria
The...
Inflammation
Solubility of Ionic Compounds

